Mixed trend on the daily chart: below its 50-day average · SuperTrend down since Oct 6 · RSI 0 (oversold) · MACD below its signal · at its 52-week low
None of the 29 investors followed here reported a position in DYNTQ in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a DYNTQ trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 14, 2025 | Holtz David BDirector | Stock Award(Grant) at price 0.00 per share. | 2K | — |
| Oct 14, 2025 | Enright Erin S. J.D.Director | Stock Award(Grant) at price 0.00 per share. | 2K | — |
| Oct 14, 2025 | Ward R. ScottDirector | Stock Award(Grant) at price 0.00 per share. | 2K | — |
| Oct 14, 2025 | Hulett AndrewDirector | Stock Award(Grant) at price 0.00 per share. | 2K | — |
| Jan 1, 2025 | Holtz David BDirector | Stock Award(Grant) at price 0.00 per share. | 2K | — |
| Jan 1, 2025 | Ward R. ScottDirector | Stock Award(Grant) at price 0.00 per share. | 2K | — |
| Jan 1, 2025 | Hulett AndrewDirector | Stock Award(Grant) at price 0.00 per share. | 2K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -99.8 | −99.8% | ||
| 2025 | 2.4 | -10.5 | -6.4 | -22.0 | -0.1 | 1.9 | -2.8 | 11.7 | -27.4 | -30.0 | -1.7 | -9.0 | −66.4% |
| 2024 | -13.7 | -3.3 | -8.3 | 14.2 | -22.7 | -32.9 | -14.3 | -27.3 | -25.2 | 13.5 | -14.1 | 0.7 | −79.3% |
| 2023 | 9.5 | -9.6 | -24.4 | -3.4 | -39.6 | -11.9 | 2.7 | -1.4 | -1.3 | -29.4 | 9.0 | 1.3 | −70.0% |
| 2022 | -17.7 | -11.4 | -0.3 | -5.7 | 10.1 | -19.2 | 5.7 | -5.6 | -18.6 | -8.1 | 0.7 | -15.0 | −61.0% |
| 2021 | 32.1 | 41.1 | -23.8 | 2.6 | -5.1 | 7.1 | 15.0 | -8.7 | 15.9 | -2.1 | -21.7 | -10.7 | +23.5% |
| 2020 | 18.1 | 95.9 | -55.0 | -3.9 | -19.9 | 32.4 | -0.0 | -20.2 | 0.0 | -16.6 | 19.8 | 15.4 | −2.4% |
| 2019 | -2.2 | -19.5 | -4.2 | -14.1 | -15.3 | 10.0 | -6.7 | -16.9 | -21.1 | -13.1 | -15.0 | 11.3 | −69.6% |
| 2018 | -8.1 | 0.0 | 13.2 | -0.8 | -1.7 | -1.7 | -1.2 | 2.1 | -1.7 | -8.4 | -0.4 | 5.0 | −5.3% |
| 2017 | 17.0 | 1.8 | 1.8 | 12.3 | -7.8 | -5.1 | -5.4 | -7.5 | -7.7 | 8.3 | 2.2 | 15.2 | +22.7% |
| 2016 | -8.8 | 5.2 | 3.2 | -1.7 | -6.2 | 10.0 | -6.1 | -6.1 | -4.6 | 6.0 | -3.8 | -7.8 | −20.6% |
| 2015 | -2.6 | -7.9 | -15.5 | -5.1 | 5.0 | 9.9 | -1.5 | -4.1 | 1.6 | 1.4 | -5.5 | -0.3 | −23.9% |
| 2014 | 6.5 | -18.0 | -18.9 | 1.4 | 7.0 | 16.6 | 10.8 | -2.2 | -3.2 | 1.3 | -3.3 | 1.8 | −6.3% |
| 2013 | 35.8 | -33.6 | 4.7 | -0.7 | -1.9 | -0.4 | -8.4 | 43.3 | -7.7 | -11.1 | 43.8 | 2.7 | +45.6% |
| 2012 | 17.6 | 1.3 | -3.7 | -6.4 | -30.2 | -1.8 | -3.9 | 2.0 | 32.7 | -21.5 | -15.7 | 32.6 | −16.2% |
| 2011 | 47.6 | -6.5 | 34.5 | 47.0 | -8.7 | -7.0 | 4.1 | -26.3 | -28.6 | -8.8 | -6.9 | 0.0 | +8.0% |
| 2010 | 39.6 | -23.3 | 10.9 | -2.0 | -27.0 | -9.6 | 7.6 | -0.2 | -4.1 | 2.9 | -3.0 | -7.2 | −26.7% |
| 2009 | 54.8 | -25.6 | -4.8 | 8.9 | 78.4 | -3.0 | 34.4 | -3.5 | -7.1 | -15.9 | 6.2 | 24.8 | +177.4% |
| 2008 | -3.1 | 2.2 | 2.9 | -5.7 | -2.0 | -26.8 | -2.8 | -10.1 | -32.3 | -7.1 | -10.3 | -11.4 | −69.9% |
| 2007 | 9.8 | -11.4 | -0.9 | 8.3 | -8.5 | 0.9 | 49.1 | -11.8 | -2.1 | 0.7 | -19.3 | -8.8 | −8.0% |
No analyst coverage for this instrument.
Dynatronics Corporation, a medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally. It offers orthopedic soft bracing products, including cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. The company markets its products under the Dynatron, Dynatron Solaris, Bird & Cronin, Hausmann, PROTEAM, and Mammoth brand names. It sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers through a network of independent dealers. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota. On January 9, 2026, Dynatronics Corporation, along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Minnesota.
No recent headlines.